Benzinga | Aug 3, 2021 04:17PM EDT

Neurocrine Biosciences Q2 EPS $0.63 Beats $0.49 Estimate, Sales $288.90M Beat $274.38M Estimate

Neurocrine Biosciences (NASDAQ:NBIX) reported quarterly earnings of $0.63 per share which beat the analyst consensus estimate of $0.49 by 28.57 percent. This is a 55.63 percent decrease over earnings of $1.42 per share from the same period last year. The company reported quarterly sales of $288.90 million which beat the analyst consensus estimate of $274.38 million by 5.29 percent. This is a 4.46 percent decrease over sales of $302.40 million the same period last year.